Navigation Links
Rigaku Oxford Diffraction Presents Latest X-Ray Diffraction Technologies at 2019 BCA Spring Meeting
Date:4/16/2019

Rigaku Corporation is pleased to announce its attendance at the British Crystallographic Association Spring Meeting (BCA 2019), Monday, April 15 to Thursday, April 18, 2019 at the Jubilee Campus of University of Nottingham.

The meeting addresses current and future developments in single crystal X-ray diffraction (SCXRD) and features a diverse range of talks, posters, workshops and exhibitions. Rigaku Oxford Diffraction is presenting information about its current portfolio of macromolecular and small molecule crystallography instrumentation.

Rigaku - a key sponsor of the event – is showing the new Rigaku HyPix-Arc 150° curved Hybrid Photon Counting (HPC) X-ray detector for single crystal diffraction applications. The detector has the highest 2? range at a single position available for the home lab, enabling the collection of more data in a single exposure with less reflection profile distortion.

Rigaku will also be hosting an afternoon users' meeting featuring talks on both single crystal and powder X-ray diffraction topics, the latter presented by Scientific and Medical Products, Ltd. (SciMed). The meeting will start at 2pm on Thursday, April 18th in Meeting Room 5, following the conclusion of the main BCA meeting, and will cover the latest developments at Rigaku in single crystal and powder X-ray diffraction, providing an opportunity to discuss users’ research, experiences, and issues.

Registration information for the European Users' Meeting is available at https://www.rigaku.com/mailers/eum2019/.

Single crystal X-ray diffraction is performed by analyzing the pattern of X-rays diffracted by a single crystal - an ordered array of identical molecules. It is the most common experimental method of obtaining a detailed structure of a molecule that allows resolution of individual atoms.

About Rigaku Oxford Diffraction (ROD)
ROD was formed as the global single crystal business unit of Rigaku Corporation after the acquisition of the former Oxford Diffraction organization from Agilent Technologies in 2015. ROD is a leader in the field of single crystal analysis, both in the field of chemical crystallography as well as well as macromolecular crystallography. Formed in 1951, Rigaku Corporation is a leading analytical instrumentation company based out of Tokyo, Japan.

For further information, contact:
Michael Nelson
Global Marketing Coordinator
Rigaku Corporation
michael.nelson(at)rigaku(dot)com

Read the full story at https://www.prweb.com/releases/rigaku_oxford_diffraction_presents_latest_x_ray_diffraction_technologies_at_2019_bca_spring_meeting/prweb16247893.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Issue 62 of The Bridge, the Materials Science Newsletter from Rigaku, is Now Online
2. Bruker and Oxford Instruments Announce Acquisition of Oxford Instruments Superconducting Wire Business by Brukers BEST Segment
3. Oxford BioTherapeutics Licenses Nerviano Medical Sciences Drug-Linker Technology to Develop Novel Antibody Drug Conjugates
4. Sound Pharmaceuticals and Oxford collaborate on a new treatment for bipolar disorder
5. Oxford Finance Provides $8 Million Senior Debt Facility to BiO2 Medical
6. BioElectronics Announces Oxford University Sponsored Study
7. The Centers for Disease Control and Prevention and Vermont Oxford Network Partner to Tackle Antibiotic Overuse and Misuse
8. Invenra and Oxford BioTherapeutics Enter Collaboration to Discover Novel Therapeutic Antibodies Targeting Cancer
9. Oxford Finance Closes $25 Million Senior Credit Facility with Entellus Medical
10. cbdMD Co-Presents Prabal Gurung's 2019 Fall/Winter Women’s Collection Launch at Bloomingdale’s New York
11. Therapy and Beyond Presents North Houston's 2nd Annual Moms Mingle for Moms of Children With Autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2019)... ... April 17, 2019 , ... ... Clinical Trial Design Strategies to Expedite Development of Oncology Drugs and Biologics’ ... alike. , Through years of experience helping sponsors manage complex oncology trials, ...
(Date:4/17/2019)... ... April 17, 2019 , ... Kennywood ... or on the autism spectrum, have an amazing experience. As part of this ... awarded by the International Board of Credentialing and Continuing Education Standards (IBCCES) to ...
(Date:4/17/2019)... ... 2019 , ... NanoFUSE Biologics announced today that ... place on Thursday, March 28, 2019 at Mary Immaculate Hospital in Newport News, ... on a 71-year-old male patient. , NanoFUSE Biologics is the only bioactive ...
Breaking Medicine Technology:
(Date:4/18/2019)... (PRWEB) , ... April 18, 2019 , ... ... selecting the best provider for their care. Through the rise of online review ... greater level of interaction and transparency when making important purchasing decisions online. In ...
(Date:4/17/2019)... ... 2019 , ... With Fentanyl overdose deaths continuing to claim lives and keeping ... by looking for an alternative to naloxone. Researchers are presenting their findings to ... Naloxone (often known by the name brand Narcan) has been utilized increasingly since the ...
(Date:4/17/2019)... ATLANTA (PRWEB) , ... April 17, 2019 , ... Kadan ... nearly 35 years, announced today that it has received both the 2019 Best of ... Pulse. These awards are granted only to the top-ranking home care providers, based on ...
(Date:4/17/2019)... (PRWEB) , ... April 17, 2019 , ... ... IBS sufferers, announced a new initiative this April to designate April 19th as ... show strong support for research & healthcare professionals in their pursuit to find ...
(Date:4/17/2019)... CHICAGO (PRWEB) , ... April 17, 2019 , ... ... Infertility Awareness Week (April 21 through April 27), in an effort to unite ... that people face when building families. To support this initiative, Fertility Centers of ...
Breaking Medicine News(10 mins):